Clinical trial · Interventional
Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis
NCT07420751CI-TRIAL-00123706completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this clinical trial is to investigate the usability of auto-captioning glasses for adults diagnosed with NF2-related schwannomatosis and loss of hearing. The primary objective of the study is to determine the feasibility and acceptability of auto-captioning glasses in this population. Participants will be asked to: * Use the glasses at their discretion for 12 weeks * Report their feedback at 3 and 12 week timepoints via online surveys and remote qualitative interviews
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| NF2-related Schwannomatosis | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Auto-captioning Glasses | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Adults with NF2-SWN and Hearing Loss
- description
- Adults with a clinical diagnosis of NF2-SWN and self reported hearing loss will use the auto-captioning glasses for 12 weeks
- interventionNames
- Device: Auto-captioning Glasses
Primary outcomes (1)
- measure
- System Usability Scale
- timeFrame
- 12 Weeks
- description
- Used to assess the usability of the auto-captioning glasses, scored from 0-100, with higher scores indicating higher usability.
Secondary outcomes (2)
- measure
- Modified Telehealth Usability Questionnaire (Satisfaction and Future Use Sub-scale)
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosis of NF2-SWN by 2022 revised criteria * Age 18 years or older at time of consent * Willing and able to sign informed consent * Access to a mobile phone with current operating software (i.e., iOS 16+ or Android 12+) and an internet connection * Does not require prescription glasses to communicate others (e.g. may use reading glasses or similar) * Resident of the U.S. * English-speaking Exclusion Criteria: * Current use of auto-captioning glasses
References
Publications (0)
Data not yet available
No reference posted for this study.